Vaccinex Stock Buy Hold or Sell Recommendation
| VCNX Stock | USD 3.60 0.11 2.96% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Vaccinex is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Vaccinex given historical horizon and risk tolerance towards Vaccinex. When Macroaxis issues a 'buy' or 'sell' recommendation for Vaccinex, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Vaccinex Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide. In addition, we conduct extensive research on individual companies such as Vaccinex and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Vaccinex |
Execute Vaccinex Buy or Sell Advice
The Vaccinex recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vaccinex. Macroaxis does not own or have any residual interests in Vaccinex or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vaccinex's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Vaccinex Trading Alerts and Improvement Suggestions
| Vaccinex generated a negative expected return over the last 90 days | |
| Vaccinex has high historical volatility and very poor performance | |
| Vaccinex has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 570 K. Net Loss for the year was (20.25 M) with loss before overhead, payroll, taxes, and interest of (13.7 M). | |
| Vaccinex currently holds about 11.4 M in cash with (17.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.27. | |
| Vaccinex has a poor financial position based on the latest SEC disclosures | |
| Latest headline from seekingalpha.com: Vaccinex reports Q3 figures |
Vaccinex current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vaccinex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vaccinex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Vaccinex Returns Distribution Density
The distribution of Vaccinex's historical returns is an attempt to chart the uncertainty of Vaccinex's future price movements. The chart of the probability distribution of Vaccinex daily returns describes the distribution of returns around its average expected value. We use Vaccinex price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vaccinex returns is essential to provide solid investment advice for Vaccinex.
| Mean Return | -0.12 | Value At Risk | -14 | Potential Upside | 11.11 | Standard Deviation | 8.65 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vaccinex historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Vaccinex Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Vaccinex, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Vaccinex back and forth among themselves.
| Shares | Ubs Group Ag | 2024-06-30 | 0.0 | Tacita Capital Inc. | 2024-06-30 | 0.0 | Point72 Asset Management, L.p. | 2024-06-30 | 116.5 K | Armistice Capital, Llc | 2024-06-30 | 94 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 2.2 K | Tower Research Capital Llc | 2024-06-30 | 1.3 K | Group One Trading, Lp | 2024-06-30 | 67.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 53.0 | Royal Bank Of Canada | 2024-06-30 | 39.0 | Bank Of America Corp | 2024-06-30 | 8.0 | Capital Advisors, Ltd. Llc | 2024-09-30 | 3.0 |
Vaccinex Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vaccinex or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vaccinex's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vaccinex stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | 0.70 | |
σ | Overall volatility | 8.77 | |
Ir | Information ratio | -0.03 |
Vaccinex Volatility Alert
Vaccinex is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Vaccinex's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Vaccinex's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Vaccinex Fundamentals Vs Peers
Comparing Vaccinex's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vaccinex's direct or indirect competition across all of the common fundamentals between Vaccinex and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vaccinex or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vaccinex's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vaccinex by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Vaccinex to competition |
| Fundamentals | Vaccinex | Peer Average |
| Return On Equity | -7.59 | -0.31 |
| Return On Asset | -4.96 | -0.14 |
| Operating Margin | (24.66) % | (5.51) % |
| Current Valuation | 8.32 M | 16.62 B |
| Shares Outstanding | 2.6 M | 571.82 M |
| Shares Owned By Insiders | 9.36 % | 10.09 % |
| Shares Owned By Institutions | 49.12 % | 39.21 % |
| Number Of Shares Shorted | 127.5 K | 4.71 M |
| Price To Book | 7.34 X | 9.51 X |
| Price To Sales | 27.09 X | 11.42 X |
| Revenue | 570 K | 9.43 B |
| Gross Profit | (13.7 M) | 27.38 B |
| EBITDA | (19.75 M) | 3.9 B |
| Net Income | (20.25 M) | 570.98 M |
| Cash And Equivalents | 11.4 M | 2.7 B |
| Cash Per Share | 0.27 X | 5.01 X |
| Total Debt | 247 K | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 8.22 X | 2.16 X |
| Book Value Per Share | (2.59) X | 1.93 K |
| Cash Flow From Operations | (17.23 M) | 971.22 M |
| Short Ratio | 0.74 X | 4.00 X |
| Earnings Per Share | 7.42 X | 3.12 X |
| Target Price | 7.0 | |
| Number Of Employees | 37 | 18.84 K |
| Beta | 0.99 | -0.15 |
| Market Capitalization | 9.64 M | 19.03 B |
| Total Asset | 3.63 M | 29.47 B |
| Retained Earnings | (339.93 M) | 9.33 B |
| Working Capital | (2.57 M) | 1.48 B |
| Net Asset | 3.63 M |
Note: Acquisition by Maurice Zauderer of 46153 shares of Vaccinex at 3.25 subject to Rule 16b-3 [view details]
Vaccinex Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Vaccinex . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Vaccinex Buy or Sell Advice
When is the right time to buy or sell Vaccinex? Buying financial instruments such as Vaccinex Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Vaccinex in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Semiconductor Thematic Idea Now
Semiconductor
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Vaccinex Stock Analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.